Return to search

Sunstone backs Forendo

Forendo Pharma, a Finnish drug developer focused on women’s health, has secured 5 million euros in funding. The investor was Sunstone Life Science Ventures. In addition to the funding, Claus Andersson, a general partner from Sunstone, joins Forendo Pharma’s board of directors.

Source: Press Release